Form 8-K Filing by bioAffinity Technologies, Inc.

This Form 8-K filing reports on an event related to bioAffinity Technologies, Inc. (the "Company") and its wholly-owned subsidiary, Precision Pathology Laboratory Services LLC (“PPLS”). The report details a succession of ownership for Village Oaks Pathology, a Texas professional association. Initially, PPLS acquired the laboratory assets of Village Oaks Pathology from Dr. Roby P. Joyce, M.D. As part of the agreement, Dr. Joyce was restricted from disposing of his equity interests in Village Oaks Pathology without consent, and Dr. James Humphreys was named as a qualified successor. In December 2025, Dr. Joyce decided to transfer his entire equity interest in Village Oaks Pathology to Dr. Humphreys. A new succession agreement was entered into on December 22, 2025, outlining restrictions on Dr. Humphreys' equity interests and provisions for automatic transfer to a new successor under certain conditions, such as death, disability, or retirement. The agreement also includes clauses to ensure the continuity of Village Oaks Pathology's business operations.